ADC Process Development Summit

The ADC Process Development Summit, held in Boston, is a premier event focused on redefining precision cancer treatment through innovative Antibody-Drug Conjugate (ADC) processes. This summit is part of the World ADC Series, bringing together over 1,500 experts in the field to share invaluable insights and foster connections that can advance ADCs as a preferred treatment option. The summit's intimate setting allowed more than 80 experts to engage in two days of focused discussions, real-world case studies, and strategic insights that tackle the technical and operational challenges of ADC process development.At the summit, attendees had the opportunity to explore essential topics such as streamlining purification strategies, optimizing drug-to-antibody ratios (DAR), and ensuring robust quality assurance measures for regulatory compliance. The event emphasized the importance of developing a scalable, efficient, and reproducible manufacturing process, addressing key challenges related to controlling impurities and executing effective technology transfers. Participants included senior directors and team leads from biologics analytical development sectors, highlighting the summit's appeal to professionals involved in early-stage development, pivotal trials, and Biologics License Application (BLA) submissions. This collaborative environment allowed attendees to benchmark their processes, troubleshoot issues, and advance their ADC capabilities with confidence, ensuring they remain at the forefront of innovation in cancer treatment.